Interestingly, the metabolic role of ACLY may be linked to cell cycle dysregulation by its binding to low-molecular-weight (LMW) cyclin E, a tumour-specific isoform of cyclin E, to enhance ACLY function [78]. This evidence concerns the gene CCNE1 and neoplasm.